Roche, Cipla launch ‘Antibody Cocktail’ for treatment of mild to moderate COVID-19

Priced at Rs 59,750 per dose, the medicine consists of an amalgamation of Casirivimab and Imdevimab drugs. Cipla will take care of the distribution of the product.

from Zee News :India National https://ift.tt/3oLjk4U